Peer-reviewed article
IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA
Tam L, Yecies D, Han M, Toescu S, Wright J et al. ·
Summary
Written by AI, not yet AICS's view · claude-haiku-4-5-20251001This is a medical research study about using advanced MRI image analysis to predict outcomes in children with a type of brain tumor called posterior fossa ependymoma. The study developed a machine learning model using imaging features from 93 children and tested whether it could predict survival better than using clinical information alone. While the imaging-based model performed better, this is a technical diagnostic study, not an evaluation of an intervention to improve child well-being.
Key points
- Study analyzed MRI scans from 93 children with posterior fossa ependymoma across five centers
- Radiomic model showed better predictive performance than clinical variables alone (concordance 0.69 vs 0.58)
- Six MRI texture and statistical features were identified as prognostically relevant
- Adding molecular subtyping data further improved the model's performance
Limitations
This is a diagnostic development study, not an intervention evaluation, so it cannot tell us whether any treatment or program improves child health outcomes. The study is described as pilot work requiring further validation with additional datasets.
Abstract
Abstract PURPOSE Posterior fossa ependymomas (PFE) are common pediatric brain tumors often assessed with MRI before surgery. Advanced radiomic analysis show promise in stratifying risk and outcome in other pediatric brain tumors. Here, we extracted high-dimensional MRI features to identify prognostic, image-based, radiomics markers of PFE and compared its performance to clinical variables. METHODS 93 children from five centers (median age=3.3yrs; 59 males; mean PFS=50mos) were included. Tumor volumes were manually contoured on T1-post contrast and T2-weighted MRI for PyRadiomics feature extraction. Features include first-order statistics, size, shape, and texture metrics calculated on the original, log-sigma, and wavelet transformed images. Progression free survival (PFS) served as outcome. 10-fold cross-validation of a LASSO Cox regression was used to predict PFS. Model performance was analyzed and concordance metric (C) was determined using clinical variable (age at diagnosis and sex) only, radiomics only, and radiomics plus clinical variable. RESULTS Six radiomic features were selected (all T1): 1 first-order kurtosis (log-sigma) and 5 texture features (3 wavelet, 2 original). This model demonstrated significantly higher performance than a clinical model alone (C: 0.69 vs 0.58, p<0.001). Adding clinical features to the radiomic features didn’t improve prediction (p=0.67). For patients with molecular subtyping (n=48), adding this feature to the clinical plus radiomics models significantly improved performance over clinical features alone (C = 0.79 vs. 0.66, p=0.02). Further validation and model refinement with additional datasets are ongoing. CONCLUSION Our pilot study shows potential role for MRI-based radiomics and machine learning for PFE risk stratification and as radiographic biomarkers.